Dyadic to Present at the ThinkEquity Partners 4th Annual Growth Conference on September 14, 2006 at 11:00 a.m. PDT (2 p.m. EDT);
08 Septembre 2006 - 2:01PM
Business Wire
Dyadic International, Inc. (AMEX:DIL), a biotechnology company,
announced today that Glenn Nedwin, Ph.D, Dyadic's Chief Scientific
Officer, Executive Vice President and President of Dyadic's
Biosciences Business, will make a presentation at the ThinkEquity
Partners 4th Annual Growth Conference to be held at the Ritz
Carlton Hotel in San Francisco on September 11-14, 2006. Dr.
Nedwin's presentation is scheduled for September 14 at 11:00 a.m.
PDT (2 p.m. EDT). A simultaneous webcast of the presentation may be
accessed by clicking the webcast link at http://www.dyadic.com. A
replay will be available for 30 days at the same internet address.
Dr. Nedwin plans to discuss the Company's progress in the
development of its technologies for the production of new, better
and more affordable products in its three core business areas: --
Biorefineries, to communicate the Company's recent advances in the
development of its patented and proprietary enzyme mixtures to make
abundant low cost sugars from agricultural plant materials (energy
crops). Sugars are currently being used to produce ethanol,
plastics and polymers to displace petroleum in a variety of
manufacturing and refining processes. -- Biosciences, to provide an
update on the Company's progress to leverage its C1 Host Technology
for use in collaboration with biotech and pharmaceutical companies
to enable them to more efficiently discover, develop and produce
new, better and more affordable human antibodies and other drugs;
and -- Enzymes, to report on the Company's progress in expanding
from its historical textile enzyme business to larger and more
profitable markets such as pulp and paper and animal feed. About
Dyadic Dyadic International, Inc., based in Jupiter, Florida, with
operations in the United States of America, Hong Kong and mainland
China, Poland and The Netherlands, is engaged in the development,
manufacture and sale of biological products using a number of
proprietary fungal strains to produce enzymes and other
biomaterials, principally focused on a system for protein
production based on the patented Chrysosporium lucknowense fungus,
known as C1. Dyadic is applying its technologies to produce enzymes
for use in converting various agricultural products (e.g. corn) and
waste products (e.g. switch grass, wheat straw, sugar cane bagasse,
etc.) into fermentable sugars, which can then be used in the
production of traditional and cellulosic ethanol as well as other
products currently derived from petroleum. Dyadic's C1 technology
also is being developed to facilitate the discovery, development
and large-scale production of human antibodies and other high-value
therapeutic proteins. Dyadic currently sells more than 45 liquid
and dry enzyme products to more than 200 industrial customers in
approximately 50 countries for the textile, pulp & paper,
animal feed, alcohol, starch, and food and beverage industries.
Cautionary Statement for Forward-Looking Statements Certain
statements contained in this press release are "forward-looking
statements." These forward-looking statements involve risks and
uncertainties that could cause our actual results, performance or
achievements to be materially different from any future results,
performance or achievements expressed or implied by such
forward-looking statements. For a discussion of these risks and
uncertainties, please see our filings from time to time with the
Securities and Exchange Commission, which are available free of
charge on the SEC's web site at http://www.sec.gov, including our
Annual Report on Form 10-KSB for the year ended December 31, 2005,
and our subsequent filings with the SEC. Except as required by law,
we expressly disclaim any intent or obligation to update any
forward-looking statements.
Dyadic (AMEX:DIL)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024
Dyadic (AMEX:DIL)
Graphique Historique de l'Action
De Juin 2023 à Juin 2024
Real-Time news about Dyadic International (American Stock Exchange): 0 recent articles
Plus d'articles sur Dyadic International, Inc.